solid tumors – Page 3 – Communicable Diseases Research

Association of COVID-19 Vaccination With SARS-CoV-2 Infection in Patients With Cancer A US Nationwide Veterans Affairs Study

암 환자의 SARS-CoV-2 감염과 COVID-19 예방 접종의 연관성 미국 전역 재향 군인 연구

Multicenter Study

Published on 2021-12-022022-09-10
Journal: JAMA Oncology [Category] COVID19(2023년), MERS, SARS, 치료기술,

SARS-CoV-2 in children with cancer in Brazil: Results of a multicenter national registry

Observational Study

Published on 2021-12-012022-10-04
Journal: Pediatric blood & cancer [Category] SARS, 임상,

[키워드] addressed age Analysis analyzed BMI Brazil Cancer cancer treatment children Clinical symptoms complex COVID-19 described diagnosed Diagnosis diagnostic Infection Laboratory leukemia male marker Measures median age mitigate Mortality multicenter National no correlation Observational cohort study oncology outcome Patient pediatric Pediatric oncology Pediatric patient Population Prognosis Result retrospective RT-PCR SARS-CoV-2 SARS-COV-2 infection severity significantly significantly higher solid tumors Strategy survival the SARS-CoV-2 virus therapeutic Treatment variable worse prognosis
[DOI] 10.1002/pbc.29223 PMC 바로가기 [Article Type] Observational Study

Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment

활성 치료 중인 암 환자의 COVID-19 감염 및/또는 백신에 대한 혈청학적 반응

Article

Published on 2021-12-012022-09-11
Journal: ESMO open [Category] SARS, 변종, 치료법,

[키워드] active treatment anti-S Anti-S1 antibody antibody response rate Antibody titer biologic BNT162b2 BNT162b2 mRNA BNT162b2 mRNA COVID-19 vaccine booster Cancer cancer patient Cancer patients Chemotherapy Chemotherapy treatment Cohort control group COVID-19 COVID-19 infection COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines domain dose evaluated Health care Health care worker humoral identify Immunocompromised Immunocompromised patient Immunocompromised patients immunogenic immunogenicity Immunologic immunologic response Immunotherapy Infection less metastatic disease multiple regression model natural infection Neutralizing antibody titer Odds ratio other treatment other treatments Patient positive positive response reduced response rate S1/S2 SARS-CoV-2 variant SARS-CoV-2 variants serologic Serologic response serologic test serologic tests serological surveillance shown significantly solid tumor solid tumors Specific subgroup subgroups the SARS-CoV-2 Treatment tumors vaccination Vaccine vaccine doses Virological were measured
[DOI] 10.1016/j.esmoop.2021.100283 PMC 바로가기 [Article Type] Article

Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials

Article

Published on 2021-11-202022-10-31
Journal: Cancers [Category] COVID-19,

[키워드] adverse effect adverse event AEs anticancer approved drugs cancer patient Cancer patients clinical clinical trial clinical trials cohort study Compound compounds COVID and cancer COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines development division drug drug combinations early-phase clinical trials Efficacy Efficacy and safety enrolled Enrollment European first dose General population Immune checkpoint inhibitors Immunotherapy include investigated Local Mild moderate MOST mRNA New novel immunotherapy Patient Patients with cancer phase one trial profiles question receive receiving required retrospective Safe Safety safety profile SARS-CoV-2 second dose simple solid tumors Support systemic AEs targeted therapy the patient the vaccine treated Treatment Trial trials Vaccine
[DOI] 10.3390/cancers13225829 PMC 바로가기 [Article Type] Article

Photodynamic disinfection and its role in controlling infectious diseases

Reviews

Published on 2021-10-272022-10-28
Journal: Photochemical & photobiological sciences : Official journal of the European [Category] COVID-19,

Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?

Review

Published on 2021-10-172024-09-02
Journal: Cancers [Category] 대상포진,

[키워드] anti-androgen resistant prostate cancer castrate-resistant prostate cancer (CRPC) Janus kinase 2 (JAK2) prostate cancer (PC) signal transducer and activator of transcription (STAT) solid tumors
[DOI] 10.3390/cancers13205204 PMC 바로가기 [Article Type] Review

SARS-CoV-2 Infection Rate in Patients With Cancer and Health Care Workers in a Chemoradiotherapy Unit During the Pandemic: A Prospective Cohort in Mexico

팬데믹 기간 동안 화학방사선치료실에서 암 환자 및 의료 종사자의 SARS-CoV-2 감염률: 멕시코의 예상 코호트

Article

Published on 2021-09-012022-09-11
Journal: JCO Global Oncology [Category] SARS, 치료기술,

[키워드] anti-SARS-CoV-2 antibody anti-SARS-CoV-2 immunoglobulin antibody Asymptomatic asymptomatic infections baseline Biweekly Cancer cancer treatment center Chain Reaction chemoradiotherapy clinical questionnaire contagious COVID-19 COVID-19 pandemic COVID-19-related symptom COVID-19-related symptoms cumulative death detect determine diagnostic events Follow-up HCW Health care Health care worker health care workers Hospitalization IgG Immunoglobulin Immunoglobulin G incidence infection rate Informed consent Interaction likelihood ratio median Mexico City Nasopharyngeal swab nasopharyngeal swabs outcomes Participants Patient patient safety Patients with cancer performed polymerase chain polymerase chain reaction positive Positive predictive value positive RT-PCR Predictive value Prevent Prospective provided Quantitative Rate receive reverse transcriptase Reverse transcriptase polymerase chain reaction RT-qPCR SARS-CoV-2 SARS-CoV-2 IgG SARS-COV-2 infection sensitivity Seroconversion seroconversion rate solid tumor solid tumors study period transcriptase Transmission Treatment tumors unit was performed were measured were recorded worker
[DOI] 10.1200/GO.21.00207 PMC 바로가기 [Article Type] Article

Pan-Cancer Analysis of Genomic and Prognostic Characteristics Associated With Coronavirus Disease 2019 Regulators

Medicine

Published on 2021-08-112022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

[키워드] ACE1 ACE2 AGT Analysis analyzed Angiotensin-converting enzyme angiotensin-converting enzyme 2 approach Atla Biomarkers Cancer cancers Clinical characteristics coronavirus disease correlated COVID-19 COVID-19 regulators database drug drugs targeting evaluated expression level genetic alteration genetic alterations genomic alteration information Interaction mechanism Methylation outcomes Pan-cancer Pathways Patient portal potential mechanism Prognosis prognostic receptor regulator response RNA-seq data sensitivity serine protease significantly single nucleotide SLC6A19 solid tumor solid tumors Therapeutics TMPRSS2 tumorigenesis Variation widespread
[DOI] 10.3389/fmed.2021.662460 PMC 바로가기 [Article Type] Medicine

Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan

일본의 코로나19 팬데믹 기간 동안 암 환자와 의료 종사자 간의 SARS-CoV-2 항체 상태의 차이

Article

Published on 2021-08-012022-09-11
Journal: JAMA Oncology [Category] MERS, SARS, 진단, 치료법,

[키워드] 95% CI antibody antibody levels antibody status anticancer Assessing assistant Cancer Cancer center cancer treatment Care Chemotherapy COVID-19 COVID-19 infection COVID-19 pandemic cross-sectional cross-sectional study defined difference enrolled Enrollment enzyme enzyme immunoassay evaluate HCW HCWs Health care Health care worker help high risk IgG IgG antibodies IgG antibody IgG levels Immune checkpoint inhibitor Immune checkpoint inhibitors immune response immunoassay IQR Japan Japanese median median age men molecular not differ nucleocapsid nucleocapsid IgG Nurse Nurses Older outcome participant Patient patients Patients with cancer Physicians Radiotherapy researchers SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 IgM SARS-COV-2 infection Seropositivity Seroprevalence serum serum levels significantly higher significantly lower solid tumors spike IgG Spike protein Spike proteins spread of COVID-19 status surgery systemic therapy the epidemic therapy Tokyo Treatment tumors were excluded were measured worker
[DOI] 10.1001/jamaoncol.2021.2159 PMC 바로가기 [Article Type] Article

Decline and incomplete recovery in cancer diagnoses during the COVID-19 pandemic in Belgium: a year-long, population-level analysis

벨기에의 COVID-19 전염병 동안 암 진단의 감소 및 불완전 회복: 1년 동안의 인구 수준 분석

Article

Published on 2021-08-012022-09-11
Journal: ESMO open [Category] SARS, 진단, 치료기술, 치료제,

[키워드] accelerated affected age Analysis Breast cancer Cancer cancer registry cancers Care children Colorectal cancer complete recovery COVID-19 COVID-19 pandemic Decline decrease diagnose diagnoses Diagnosis diagnostic diagnostic delay diagnostic procedure diagnostic procedures distribution Evidence evidence of facilitate female First wave group head and neck cancer Health Health care hematological Hematological malignancies Hematological malignancy identify impacted invasive Laboratory less lung magnitude Melanoma men neoplasm obvious symptoms older patient older patients organized Pancreatic cancer pathology Population screening population-based cancer registry. Prognosis reduction reduction in reductions reflected registry risk solid tumors stimulate Suspension These data tumors women
[DOI] 10.1016/j.esmoop.2021.100197 PMC 바로가기 [Article Type] Article